Life sciences news
-
ANeuroTech receives positive feedback from the FDA for its pivotal Phase IIIb development programme for ANT-01 as an adjunctive anti-depression drug for Major Depressive Disorder
Tuesday July 5th 2022
Read more
-
Confo Therapeutics awarded EUR 1.7M VLAIO grant to expand application of ConfoBody® drug discovery and development technology in rare diseases
Tuesday June 28th 2022
Read more
-
MRM Health starts clinical trial with next-generation optimized consortium therapeutic MH002 in Pouchitis
Tuesday June 28th 2022
Read more
-
Voxdale opens Dutch branch at innovation hub Brainport Eindhoven
Tuesday June 28th 2022
Read more
-
ImmuneWatch signs licence agreement with UAntwerp and UZA and officially becomes a university spin-off company
Friday June 24th 2022
Read more
-
argenx receives positive CHMP opinion for efgartigimod for the treatment of adult patients with generalized myasthenia gravis in Europe
Friday June 24th 2022
Read more
-
Charles River and Ziphius Vaccines collaborate to manufacture saRNA-based vaccine
Thursday June 23rd 2022
Read more
-
Fujirebio acquires ADx NeuroSciences and confirms its intentions to bring better and earlier neurodegenerative disease diagnostic solutions to the global diagnostics industry
Thursday June 23rd 2022
Read more
-
Become a flanders.bio member
Your news here?
-
Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies
Wednesday June 22nd 2022
Read more
-
Biocartis announces new agreement with AstraZeneca for the development and marketing of a companion diagnostic test for Tagrisso®
Wednesday June 22nd 2022
Read more
-
IDDI announces RTSM partnership with Clario
Wednesday June 22nd 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
